Your browser doesn't support javascript.
loading
Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance.
Liu, Juan; Ma, Xiaowei; Jin, Shubin; Xue, Xiangdong; Zhang, Chunqiu; Wei, Tuo; Guo, Weisheng; Liang, Xing-Jie.
Afiliación
  • Liu J; Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, and Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China , Beijing 100190, China.
  • Ma X; Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, and Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China , Beijing 100190, China.
  • Jin S; Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, and Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China , Beijing 100190, China.
  • Xue X; Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, and Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China , Beijing 100190, China.
  • Zhang C; Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, and Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China , Beijing 100190, China.
  • Wei T; Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, and Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China , Beijing 100190, China.
  • Guo W; Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, and Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China , Beijing 100190, China.
  • Liang XJ; Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, and Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China , Beijing 100190, China.
Mol Pharm ; 13(5): 1723-30, 2016 05 02.
Article en En | MEDLINE | ID: mdl-27070828
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Óxido de Zinc / Doxorrubicina / Adyuvantes Farmacéuticos / Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Nanopartículas Límite: Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Óxido de Zinc / Doxorrubicina / Adyuvantes Farmacéuticos / Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Nanopartículas Límite: Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: China